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In recent years, there has been an exponential increase in 
digital data and calls for participation in human research 
through the provision of personal information for central-
ized large-scale data repositories, especially in the medical 
sciences. This phenomenon warrants an investigation of 
when and why individuals voluntarily provide data or with-
draw their participation (Broekstra et al., 2017). The overall 
increase in digital data repository has raised concerns 
among experts as well as participants in centralized large-
scale data repository about autonomy, privacy, and respon-
sibility (Mittelstadt et al., 2016; Mittelstadt & Floridi, 2016; 
Sorani et al., 2015; Stricker, 2017). Innovative methods 
applied in centralized large-scale data repository and the 
linking of personal data, such as blood samples, to other 
types of health and nonhealth information permit an even 
wider range of data use than do traditional research methods 
(Prainsack & Buyx, 2013; Steinsbekk, Ursin, et al., 2013).
Such data usage, however, deviates from the ambit of 
current standards for safeguarding participants and nonpar-
ticipants against violations of integrity, such as standard 
informed consent and anonymization procedures, and 
methods of protecting data (Barocas & Nissenbaum, 2014; 
boyd & Crawford, 2012; Keymolen, 2016; Mittelstadt & 
Floridi, 2016; Robinson et al., 2013). Moreover, it raises 
questions regarding the confidentiality of personal data, 
possible stigmatization, and uncertainty about who has 
access to the data (boyd & Crawford, 2012; Gibson et al., 
2017; Graeff & Harmon, 2002; Mittelstadt & Floridi, 2016; 
Rivera et al., 2017). Health and medical care will be priori-
tized in relation to science and innovation over the next 15 
years (Eurobarometer, 2014). Therefore, a study of the dif-
ferent perspectives of stakeholders in human research 
entailing centralized large-scale data repositories on data 
sharing and trust is pertinent. Specifically, we compared the 
perspectives of ex-participants, participants, and nonpartic-
ipants in biobanks for facilitating human research in the 
medical sciences.
With the establishment of biobanks, concern has shifted 
from questions of privacy to those of trust (Kelley et al., 
2015; Mittelstadt & Floridi, 2016). Biobanks store large 
quantities of biological specimens as well as data extracted 
from questionnaires and measurements. They are aimed at 
facilitating studies on patients with specific diseases or pro-
spective studies on the onset and progress of chronic diseases 
(Krokstad et al., 2013; Scholtens et al., 2015; Sudlow et al., 
2015; UK Biobank Coordinating Centre, 2007; van Staa 
et al., 2016). Studies of biobanks, entailing extensive data 
repository over a long duration, differ from small-scale or 
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cohort studies. Centralized information storage in biobanks 
inevitably poses a threat to participants’ privacy. The decision 
to participate in a biobank entails accepting unknown short-
term and long-term privacy risks concerning the confidential-
ity of personal data, the use of such data for unintended 
research purposes, or possible stigmatization (boyd & 
Crawford, 2012; Gibson et al., 2017; Graeff & Harmon, 
2002; Mittelstadt & Floridi, 2016; Nobile et al., 2016; Rivera 
et al., 2017). This situation results in a social dilemma in 
which the collective interest of promoting the public good 
and the individual interest of keeping data or information pri-
vate are opposed. Trust may reduce the complexity of this 
dilemma through general assumptions whereby an unfamil-
iar world or future is simplified, thus enabling decision mak-
ing on risk taking (Luhmann, 1979). Studies have shown that 
trust in biobanks, health care providers, and other public 
institutions is a key factor in determining individuals’ will-
ingness to participate in epidemiological research and to pro-
vide personal data to biobanks (Critchley et al., 2012; Gaskell 
et al., 2013; Hansson, 2005; Kaufman et al., 2009; Kettis-
Lindblad et al., 2006; Lemke et al., 2010; Nobile et al., 2016; 
Rahm et al., 2013).
Currently, biobanks and other facilities used in human 
research attempt to enhance or change the complexity, vol-
ume, and nature of their data repositories to optimize them 
(Mittelstadt & Floridi, 2016). Researchers and data collec-
tors seek to link individuals’ data to other types of personal 
data available within analyses of large data repositories to 
illuminate complex patterns and build predictive models 
(Barocas & Nissenbaum, 2014; Nuffield Council on 
Bioethics, 2015). These “big health data” can emerge out of 
detailed data revealing individuals’ characteristics, behav-
iors, and preferences, for example, through combined anal-
yses of questionnaires and genomic, register, sensory, 
satellite, and social media data. Accordingly, voluntary par-
ticipation in research in a context of openly shared informa-
tion requires a greater degree of trust in the data repositories 
and their use in human research, compared with a context in 
which enrichment or sharing of data does not occur (Gibson 
et al., 2017; van Staa et al., 2016).
Trust, however, is a concept that is complex and difficult 
to grasp (Parks et al., 2015). Although trust seems to be a 
requirement for participation in research, its function within 
decision making regarding participation or withdrawal 
remains unclear. Moreover, the distinction between trust and 
distrust is still a matter of debate, with some scholars view-
ing trust and distrust as two ends of a single continuum, 
whereas others view them as distinct (Keymolen, 2016; 
Luhmann, 1979; Saunders et al., 2014). Trust can be defined 
as an individual’s willingness to be vulnerable without eval-
uating the behavior and intention of another person that 
automatically leads to a decision on whether or not to accept 
the risk (Ferrin et al., 2006; Mayer et al., 1995). Other schol-
ars regard trust as a cognitive construct relating to the 
outcome of an individual’s reasoning process regarding their 
own vulnerability when evaluating others’ behaviors and 
intentions (Bhattacharya et al., 1998; Lewicki et al., 1998). 
The contradictory findings of studies on trust and biobank-
ing lend support to both views. According to the findings of 
a study conducted in the United States in 2009 (n = 4,659 
respondents), regardless of trust, privacy remains an impor-
tant issue for potential participants in biobank studies, indi-
cating the prevalence of automatic judgments (Kaufman 
et al., 2009). However, the findings of another study indicat-
ing that privacy concerns were less salient in decisions to 
participate in a biobank study when high levels of general-
ized trust existed support a conception of trust as a cognitive 
rational construct (Gaskell et al., 2013).
It is therefore important to understand why and under 
what conditions individuals are willing to trust a biobank 
with their personal data and to identify specific conditions 
that contribute to a reduction of this trust (Nobile et al., 
2016; Petersen et al., 2014). In particular, ex-participants’ 
reasons for withdrawal can yield valuable insights into the 
process of trust building. A comparative study encompass-
ing ex-participants, participants, and nonparticipants in a 
biobank that has introduced new methods for optimizing 
data repositories in an open context of information sharing 
would advance knowledge regarding the pathways that lead 
to the acquisition or loss of trust. Several studies have 
focused individually on ex-participants, participants, and 
nonparticipants (Critchley et al., 2016; Gaskell et al., 2013; 
Nobile et al., 2013; Steinsbekk, Ursin, et al., 2013), although 
empirical investigations of ex-participants are somewhat 
limited (Ridgeway et al., 2013). However, few studies have 
examined these groups simultaneously. Therefore, we 
explored the conditions under which individuals voluntarily 
entrust a biobank with their personal data and the reasons 
why trust sometimes decreases over time.
Method
Data Collection
We conducted semi-structured individual interviews, as 
they enable an in-depth exploration of respondents’ percep-
tions, events, and experiences relating to centralized large-
scale data repository and research (non)participation. 
Moreover, their opinions and statements can be triangulated 
and clarified (Kvale, 2007, p. 11). We developed an inter-
view topic guide and applied a narrative approach that left 
room for discussion of unanticipated themes. This narrative 
approach was partly derived from the method used in the 
DIPEx project (Ziebland & McPherson, 2006) that focused 
on personal experiences of health and illness.
The interview topic guide, shown in Table 1, was devel-
oped on the basis of six current themes identified in the sci-
entific literature on (non)participation in biobanking, public 
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goods, trust, and data sharing (Balliet & Van Lange, 2013; 
D’Abramo, 2015; Gaskell et al., 2013; Kaufman et al., 
2009; Mittelstadt et al., 2016; Mittelstadt & Floridi, 2016; 
Nobile et al., 2016, 2013; Parks et al., 2013; Sorani et al., 
2015; Steinsbekk, Myskja, & Solberg, 2013). The follow-
ing themes were identified: (a) becoming a (non)partici-
pant, (b) objective aspects of participation (e.g., general 
feelings, tasks, and feedback), (c) subjective aspects of par-
ticipation (e.g., expectations of accomplishment and feel-
ings of identification), (d) understandings of and attitudes 
toward centralized data repository and linkage, (e) per-
ceived benefits and threats relating to centralized data 
repository and linkage, and (f) decisions on whether or not 
to provide personal data. The interview topics were subse-
quently derived from these themes.
All of the interviews were conducted by one member of 
the research team with training and experience in interview-
ing techniques (R.B.). Current participants in Lifelines, a 
Dutch population-based biobank, were interviewed follow-
ing their regular visits to the Lifelines research site. Most of 
the interviews were held at this site or in a room allocated 
for the interviews at the University Medical Center 
Groningen. All four ex-participants from Lifelines and eight 
of the fifteen nonparticipants were interviewed at their 
homes at their request. Each interview covered all of the 
topics in the guide and lasted between 30 and 65 min, 
depending on when saturation was reached in interviews. 
The interviews were audio-recorded with the consent of the 
interviewees. Only one interviewee denied permission for 
audio recording the interview, but allowed notes to be taken. 
All of the recordings were transcribed by an independent 
professional organization. The complete study design pro-
tocol received ethical approval from the Medical Ethics 
Review Board.
Recruitment and Sampling
Maximum variation sampling was applied to recruit inter-
viewees (Coyne, 1997). Consequently, a heterogeneous 
sample was obtained (Baker & Edwards, 2012; Mason, 
2010). Between August and September 2016, a total of 36 
individuals were interviewed: 17 had participated in 
Lifelines, 4 were ex-participants, and 15 did not participate 
in Lifelines. In this article, we refer to these distinct groups 
of interviewees as “participants,” “ex-participants,” and 
“nonparticipants.” Table 2 shows the characteristics of each 
of the interviewees. The average age of the interviewees 
was 45 years (a range of 20–68), and 17 interviewees (47%) 
were male.
We recruited interviewees partly from the Lifelines bio-
bank. Lifelines is a multidisciplinary population-based pro-
spective cohort study focusing on the health and 
health-related behaviors of persons who have been living in 
the Northern Netherlands since 2006. The study has a 
unique three-generational design and employs a broad 
range of investigative procedures for assessing the biomedi-
cal, sociodemographic, behavioral, physical, and psycho-
logical factors that collectively contribute to the health of 
Table 1. Interview Topics and Illustrative Questions.
Topic Example questions
Association with biobank How did you get involved?
Decision of (non)participation What were your considerations?
Reality Was your experience as expected or not?
Future Will you participate in Lifelines or in another centralized large-
scale research project in the future?
Overall perception How is participation in Lifelines perceived in general?
Tasks How are the tasks related to participation in Lifelines perceived?
Feedback What do you think of the feedback on your data you (would) 
receive?
Outcome hoped for What motivates you to participate?
Benefits What are the benefits and opportunities relating to participation?
Disadvantages What are the risks and disadvantages relating to participation?
Definition What are centralized large-scale data repositories?
Attitudes toward large-scale centralized data repositories Are your attitudes toward collection, linking, and use of these data 
generally positive or negative?
Benefits of large-scale centralized data repositories What are the benefits of collecting, linking, and using data?
Risks posed by large-scale centralized data repository What risks are posed by the collection, linking, and use of data?
Personal balance of benefits and threats From your personal perspective, how are these considerations 
balanced?
Societal balance of benefits and threats From a societal perspective, how are these considerations 
balanced?
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the general population and to incidences of disease, with a 
special focus on multimorbidity and complex genetics 
(Scholtens et al., 2015). The recruitment of new participants 
for the Lifelines project stopped in 2013. To ensure their 
privacy, participants and ex-participants were recruited by 
the Lifelines organization. Ex-participants who had ended 
their Lifelines’s participation in the last 2 months prior to 
the commencement of our study in August 2016 were 
invited by phone to participate in our study. The invitation 
was communicated by Lifelines in the last stage of the with-
drawal procedure of Lifelines, but the invitation protocol 
was written by the researchers of this study (R.B. and J.A.). 
Moreover, nonparticipating partners of the Lifelines partici-
pants were invited by the organization. Ex-participants 
were the least willing to participate in our study. Although 
we invited ninety such individuals, only four consented to 
participate (4.44%). This response rate was significantly 
lower than those of participants and nonparticipants (22.2% 
and 24.9%, respectively). The reasons given by invitees for 
not participating in our study were “no interest,” “not avail-
able,” and “not willing to invest more time in Lifelines or its 
studies.” Although our sample of ex-participants is too 
small to allow for generalizations, we nevertheless obtained 
the in-depth information that we sought. All nonparticipants 
were members of the public whom we recruited through 
personal face-to-face invitations issued at the entrance of a 
central public library and through personal or general writ-
ten invitations that followed the same invitation protocol 
Table 2. Respondents’ Characteristics.
Respondent Sex Age Occupational field Participation status
1 Female 67 Human resources Participant
2 Male 42 Transportation Nonparticipant
3 Female 60 Education Nonparticipant
4 Male 30 Legal and social work Participant
5 Male 52 Photography and architecture Ex-participant
6 Male 60 Municipality Nonparticipant
7 Female 37 Home maintenance Ex-participant
8 Male 26 Warehouse maintenance Participant
9 Female 59 Retail Participant
10 Male 33 Entrepreneur Participant
11 Male 20 Student Participant
12 Female 53 Law Participant
13 Male 30 Student Nonparticipant
14 Male 66 Mechanical engineering Participant
15 Male 55 Home maintenance Nonparticipant
16 Female 29 Publisher Nonparticipant
17 Female 50 Entrepreneurship Nonparticipant
18 Female 68 Retired Participant
19 Male 54 Management Participant
20 Female 27 Energy policy Nonparticipant
21 Female 39 Health care Participant
22 Female 50 Health care Participant
23 Female 27 Human resources Nonparticipant
24 Female 46 Education Participant
25 Male 45 Municipality Participant
26 Female 65 Farming Nonparticipant
27 Female 43 Librarian Ex-participant
28 Female 51 Social work Ex-participant
29 Female 37 Management Participant
30 Male 33 Engineering Nonparticipant
31 Male 60 Human resources Nonparticipant
32 Female 33 Home maintenance Nonparticipant
33 Male 45 Management Participant
34 Female 63 Retired Participant
35 Male 34 Business development Nonparticipant
36 Male 49 Entrepreneurship Nonparticipant
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issued via various social networks as well as on online and 
offline platforms. Our recruitment and sampling was in 
accordance with the approval of the Medical Ethics Review 
Board.
Data Analysis
We analyzed each individual phrase of all 36 interview tran-
scripts in the context of the overall interview content, and, 
where appropriate, we generated or assigned content-related 
codes. Codes could be applied multiple times in a single 
transcript, and phrases could consist of multiple codes. 
Codes with related content were grouped together, and 
these groups were subsequently categorized into themes. 
We developed an initial coding protocol after conducting a 
close reading of three transcripts. This coding protocol was 
evaluated by two or three researchers working on each tran-
script through an iterative process of cross-checking the 
individual transcript analyses. After consensus had been 
reached about the content of codes, groups, and themes, the 
resulting coding protocol was finalized and used for the 
remaining transcripts. There was overall agreement on the 
coding. When different codes were used, consensus was 
reached through discussion. Five researchers were involved 
in coding the transcripts. Six random transcripts were coded 
by at least three researchers. Subsequently, one researcher 
coded all of the transcripts, whereas the other researchers 
coded a limited number of transcripts. In line with the pro-
tocol, the results of the interviews were categorized into 
four themes for ex-participants (EP), participants (P), and 
nonparticipants (NP). One of these themes, “Attitude 
toward centralized data repository and linkage in the con-
text of biobanking,” was influenced by our topic guide, 
given the focus of discussions during the interviews prior to 
the analysis. The prominence of the other themes did not 
emerge directly from our topic guide but was revealed by 
the data. The validity of this process of identifying themes 
is confirmed by the adaptive theory on qualitative research, 
which allows for such theoretical influence within research 
(Layder, 1998). Transcripts were primarily analyzed using a 
qualitative data analysis software package, Atlas TI version 
7, to enable the retracing and evaluation of quotes along 
with their codes, groups, and themes (Friese, 2013).
Results
We identified multiple conditions that relate to experienc-
ing the trust required to provide personal data in the context 
of biobanking and centralized large-scale data repository. 
However, interviewees found it difficult to explain the rea-
sons for this trust. For example, one interviewee (NP17) 
provided the following explanation: “I can’t express it in 
words; it’s a feeling.” Our analysis of the interview tran-
scripts revealed four major themes that featured in the 
formation of trust and in decisions made by individuals 
about sharing their data. The first theme that emerged from 
the data of unique quotes was data repository aimed at ben-
efiting the public. A second theme was organizational 
aspects of the biobank as a data collector, focusing on how 
the biobank is organized to provide a context in which data 
are used safely. The third theme was characteristics of the 
collected data, which concerned the type of data requested 
and its relevance for research. The last theme was control 
over personal data maintained through informed consent. 
This theme related to the influence of interviewees’ percep-
tions of informed consent in line with their intention of 
maintaining control over the personal data that they 
provided.
Data Collection Aimed at Benefiting the Public
The interviewees characterized the context of medical sci-
entific research as a quest aimed at improving public health. 
Although ex-participants as well as several nonparticipants 
expressed a lack of trust in public goods, and especially in 
medical scientific research, participants and the majority of 
nonparticipants perceived the context of medical scientific 
research to be generally trustworthy and affirmed their trust 
in Lifelines as a public good. For example, Lifelines was 
widely perceived as a charitable organization, as observed 
by one nonparticipant (NP13): “If I understand the question 
correctly, for me it is actually almost [like] a charity, in 
which I would participate. [But] instead of money, I give 
my time.” Participants placed considerable value on the 
objective of benefiting the public. Several interviewees, 
mostly participants, stated that they would be unwilling to 
provide their personal data if the research was primarily 
aimed at providing financial gains for just a small group of 
people, such as the managers or shareholders of Lifelines. 
One participant (P4) stated, “Well, I think it’s different. If it 
is for a [for-] profit organization then I think . . . look, that’s 
not why I participated in it.” Another participant (P14) pro-
vided the following explanation:
I see someone who wants to sell a washing machine differently 
from someone who wants to collect data about a certain disease 
in a certain family. Because the first one tries to sell a washing 
machine through data [received] from my laptop. That data is 
passed on just for personal gain. He wouldn’t otherwise [ask 
for it]. I don’t have that feeling with Lifelines [as data 
repository]. . . . Lifelines aims to make someone better, but 
then your offspring instead of yourself.
By contrast, most nonparticipants and a few participants 
were less concerned about this objective. They expressed 
their willingness to share their data in return for personal 
financial gain if they were interested in the research topic. 
This was expressed by one of these participants (NP2) as 
follows:
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Yes, if they have a commercial interest, I want them to share 
their profit as well. Then I’m going to look at it in a different 
way. If you were to make a profit, I would like you to say so.
Organizational Aspects of the Biobank as a 
Data Collector
All four ex-participants stated that they had withdrawn their 
participation because they were disappointed to some extent 
in the organizational aspects of the biobank, which contrib-
uted to a reduced level of trust. For three of four of the ex-
participants, the extensive scale of data repository was a 
critical factor influencing their distrust because they wor-
ried about the use of their personal data in Lifelines and the 
preservation of their anonymity within such a large-scale 
project. They perceived centralized large-scale data reposi-
tory to be valuable for researchers, but this also entailed an 
increased risk. Two respondents explained,
I believed that it would only be used within the hospital or at the 
University Medical Center. But it goes further in my opinion. . . 
. See, when you develop medicine or something like that, you 
need information about large groups of people. I’ve heard that 
even secret services and the police are interested in DNA 
material. There is no other large biobank in existence apart from 
this one with all of its information. From a commercial 
perspective, this is of course very interesting. (EP5)
Well I believe your data [at Lifelines] are no longer anonymous. 
I just don’t believe that [data are anonymous] anymore. That 
doesn’t concern me a lot. Only you don’t know which way 
things are going. . . . You never know where your [medical] 
data is going to end up and how it will be used or valued. 
(EP27)
All participants and most nonparticipants believed, how-
ever, that the larger renowned institutes were more compe-
tent than smaller institutes because they perceived them to 
be “better equipped,” “more solidly financed,” and “more 
experienced in handling their participants’ information.” 
They did not worry about privacy threats within Lifelines 
because of the substantial number of participants who 
would be affected if data were to be leaked or misused. As 
one participant (P10) observed, “The bigger it gets, the 
more anonymous [it becomes].” They assumed that data 
were secure. As one nonparticipant (NP16) explained,
No, well I just assume that the information will be anonymous 
and wouldn’t become public. . . . That is something you may 
expect not to happen. You need to take care of security breaches 
or data leakages when designing such large-scale research.
Moreover, the ex-participants had expected more effec-
tive communication regarding privacy, aims, and feedback 
on their results. Their perception of the lack of proactive 
communication of the organization and its representatives 
was the final factor prompting their distrust. One ex-partic-
ipant (EP7) described,
You have to hand in blood and urine, but you never get an 
answer [feedback on results]. Yes, if it’s really bad, they will 
answer, but by then it is too late. Otherwise they won’t give me 
an answer, for example “That’s good and that’s for the lungs 
and the heart.” They don’t answer that. . . . You don’t get an 
answer on whether the heart is still good or not.
All of the participants and nonparticipants indicated that 
their trust was also based on the anticipated quality and 
motives of the employees or other representatives of the 
organization. They mentioned that representatives’ compe-
tencies, measured, for example, by the expected university 
degree qualification, influenced levels of trust. Moreover, 
“professionalism” signaled trustworthiness. Such percep-
tions of “professionalism” were based on the formal and 
consistent behavior of the biobank representatives (e.g., 
being friendly and calm). This was explained by one respon-
dent (P8) as follows: “It is true that they always take a look 
at you; they are interested, so to speak. . . . I think that it is 
very important to show an interest in the people who are 
visiting.”
None of the ex-participants, participants, or nonpartici-
pants had a comprehensive understanding of how security 
measures and purpose limitations for data repositories are 
applied in medical scientific research in general, and spe-
cifically by Lifelines. This was a factor influencing the 
development of distrust or trust among interviewees. In 
light of their negative experiences that reinforced their per-
sonal beliefs, the ex-participants (EP7 and EP8) associated 
Lifelines with poor medical research and care and with 
(pharmaceutical) business (EP5 and EP27). As one of them 
(EP7) explained, this perception was based on information 
acquired indirectly:
I heard rumours in the newspapers and so forth that some 
general practitioners had stated that one should not participate 
in it. Moreover, I heard via an acquaintance who works in IT 
and was involved partly [in Lifelines] that it works a bit like 
that [business].
Neither of the above assumptions is backed by objective 
evidence. Three of the ex-participants (EP5, EP27, and 
EP28) and some of the nonparticipants were convinced that 
Lifelines was unable to guarantee the anonymity of the 
data, which could result in potential misuse of data by the 
government or by health insurance companies. As one non-
participant (NP23) observed,
I wonder what a government does with this kind of information. 
They are not doctors or hospitals, you know. . . . So what do 
you want to do with them? I can also imagine that they would 
like to share this with health insurers or people like that. Then 
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I think, sorry, but if that means that in 10 years’ time, for 
example, I will need enormously expensive medicines, then 
my health insurer doesn’t need to know. So it depends a bit on 
who and for what purposes.
Lifelines provided participants with information about 
security measures and strictly regulated methods that were 
deployed at the onset and during their participation via 
information leaflets, informed consent forms, and newslet-
ters. However, none of the participants could explain in 
detail how their donated material was being used, stored, 
and shared. One participant (P10) stated,
What you see and the information you get, that will be 
sufficient. Yes, it sounds very naive, but you can’t really do it. 
. . . Going there on one visit, you’re not going to ask: “Show me 
what you’re doing.” No, you don’t do that. You just assume 
that this is good.
As one participant (P4) clarified, the biobank was per-
ceived as trustworthy because of its link with the University 
of Groningen and with the University Medical Center 
Groningen:
I believe that the University Medical Center is the mother of 
the organisation. That is one of the most important organisations 
in the medical sciences, here in the North. . . . That scientific 
element of the research and the organisation is at the top of my 
list of factors that play a role. Well, if it wasn’t scientific, not 
linked to the university, then I would have to think about it 
again perhaps.
Characteristics of Collected Data
Interviewees mentioned that the sensitivity of the data that 
they provided, and hence the level of trust required, was 
influenced by the range of collected data. Interviewees sug-
gested that the aim of the research should match the data 
requested. Two ex-participants stated that the broad range of 
data collected by Lifelines was an important concern for 
them influencing their withdrawal as participants. In their 
view, if, in addition to medical details, the data encompassed 
supplementary information on aspects of their personal 
lives, such as their financial information, then such data 
would be more sensitive and misuse of the data could have a 
significant impact on their lives. According to one ex-partic-
ipant, it could be explained as follows (EP27): “before that 
[negative experiences during visits], I had seen a documen-
tary about privacy. So that may have been one of the factors 
because you don’t know what the consequences of [sharing] 
your information are.” All of the ex-participants and most of 
the nonparticipants had concerns about the possible abuse of 
their data in the future and were wary about providing data 
to the biobank, especially via data linkages. Some of them 
felt that a future trend of organizations controlling people’s 
lives was likely. For example, one nonparticipant (NP15) 
stated, “But if you have a lot of data, then you can manipu-
late people. . . . In the end, you can use every piece of infor-
mation about someone to control him or her.” The distrust of 
these interviewees mainly stemmed from centralized large-
scale data repository outside the scope of scientific research, 
such as data extraction from social media or web browsers, 
and especially search engines. However, they also men-
tioned other elements of distrust relating to such data reposi-
tory in the context of medical scientific research. Thus, a 
participant (P1) made the following observation: “Well a 
very good example is that this knowledge will enable you to 
potentially exclude people from insurance. . . . That is some-
thing that frightens me.”
These concerns were also shared by other interviewees 
to a lesser extent. One nonparticipant (NP16) described the 
following concern: “If they acquire data on other aspects of 
our lives, then they truly become ‘Big Brother’ . . . they can 
really dig into your life.” More specifically, these interview-
ees were concerned about the possibility of the Lifelines 
database being linked to data held by institutes that did not 
focus on health care, for example, Statistics Netherlands or 
the Dutch Tax authority. This concern is expressed in the 
following quote:
For example, my tax information does not seem to me to be 
relevant for Lifelines. That is my intuitive feeling. If someone 
could explain to me why this information is relevant, that could 
change my opinion. However, my primary response is that it is 
not necessary to provide such information. (NP30)
The interviewees who had concerns about centralized 
large-scale data repository expressed doubts as to whether 
their personal data would be used in a way that they per-
ceived as nonthreatening in the future, given Lifelines’s 
linkages with such institutions.
Yes, they can dig into all your facets of life. Of course, medical 
information is already quite personal. . . . The most personal 
thing you can know about someone. But if they also want to see 
your pay check and so on, it might well be a matter of concern. 
(NP16)
Several nonparticipants and some participants, however, 
perceived opportunities in addition to risks relating to par-
ticipation in research and the linking of personal data. Their 
interest in and support of medical scientific research were 
decisive factors influencing their consent to participate in 
this centralized large-scale data repository. They stated that 
they would supply a broad range of requested information 
providing that certain conditions were met, such as adher-
ence to their informed consent and its importance in relation 
to a relevant research context. One participant (P17) stated 
that “if they could make it clear to me why that is important, 
I would consider it. I wouldn’t just say beforehand ‘oh yes, 
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just take it.’” Another participant (P9), who had reserva-
tions, observed, “Well, if it is about your well-being and 
your health, then I think keep [the data request] to that 
theme.” These participants mentioned having a gut feeling 
that something could be wrong with data sharing in general 
or that their privacy could be threatened after discussing 
their data contributed to the biobank. These apprehensions 
mainly stemmed from their conception of a future entailing 
an increasing risk of data being misused by organizations to 
influence behavior. One participant (P1) provided the fol-
lowing explanation:
Many people do these things and what they will do with that 
huge mountain [of data]. . . . I fear no one knows anymore what 
can be done or what cannot be done with it. There are no inputs 
into this matter, so to speak. So . . . abuse is also obvious or 
conceivable.
Despite these apprehensions, however, the interviewees 
felt that the provision and linkage of their data to the bio-
bank was inevitable, given the high degree of relevance of 
their medical information. A participant (P4) stated,
It is a bit scary. Nowadays they want to know everything about 
you, and even the government knows where you are, where 
you drive, where you check in with a public transport card. But 
yes, that is also the time we are living in. So I think we should 
go along with that.
None of the other participants had any reservations about 
the increasing provision and linking of their personal data to 
the biobank via other organizations because they had noth-
ing to hide within the specific context of human research in 
medical sciences. The objective of health care justified their 
full contribution to the biobank and to medical scientific 
research. Two participants explicitly stated that if Lifelines 
considered financial information necessary for research 
purposes, then they would provide it without stipulating any 
conditions:
How far can they go with that [data collection]? Extremely far 
for me. . . . if that requires me to reveal sensitive things, like 
what diseases I have had, how my sex life is or how much I 
drink, no problem. Even if they put it on the Internet, if I [help 
to] make someone better with it [the information], then they 
should do that. (P10)
Another participant (P11) provided the following 
explanation:
You give away data, and for the rest, you are not 100% sure if 
anyone will ever leak something . . . or that . . . it will be used 
against you ever. . . . But I don’t attach a great deal of importance 
to that if I compare that with what kind of benefits there can be, 
so to speak.
Control Over Personal Data Maintained Through 
Informed Consent
The interviewees’ subjective perceptions of informed con-
sent given to the biobank played an important role in their 
decisions to withdraw their participation or contribute data. 
All of the ex-participants indicated that their reason for 
withdrawing was to take back control over their data 
because they felt that they had been misinformed or given 
insufficient information. One of them (EP5) stated,
Well, I couldn’t find anything on the Internet, for example, 
from the Lifelines organization on what exactly they do with 
all the information. That was nowhere to be found. Then I 
thought, what’s secret? . . . I believe that journalists have been 
looking for that [information] too. I couldn’t find anything 
about it. . . . I think they should disclose that much more. What 
exactly do they do with it? What exactly is their goal?
Thus, they lost trust not only in the biobank but also in 
data sharing in general or in health care. Their trust dimin-
ished after they were misinformed about data management 
or the nonprofit policy, or when they developed a distrust of 
data sharing in general. It also diminished after they gained 
access to new information or exposure to media debates 
about research and data security. Although some interview-
ees from the group of participants had given their consent, 
they were still somewhat hesitant to provide their personal 
data because of a perception of loss of control: “You don’t 
have any control. . . . My problem concerns what they do 
with it. You have to have that confidence in them, which I 
find a bit difficult.” (P3)
One third of the interviewees, mainly participants, men-
tioned that providing personal data to the biobank would 
not be an issue because informed consent had been or would 
be given. They felt that they had adequate control over their 
donated personal data and could “always” retract their data 
if necessary:
If I must think about everything, that’s simply not me. “Oh, 
what is he going to do with my data?” . . . I don’t care. I just 
don’t say things that I don’t want to tell them. (P22)
Nonparticipants appeared to be more cautious and val-
ued the personal data they would provide as sensitive. For 
example, one nonparticipant (NP3) explained,
Look, if I am part of a group, and I have to make a choice. . . . 
I have no control. . . . What concerns me is what they do with 
it. You must give them that trust, but I find that a bit difficult. 
In my opinion, it is the same with politics. Municipal politics, I 
find that easier. Otherwise it’s [politics] too broad.
Although views on the value of the contributed personal 
data differed, the procedure of informed consent was widely 
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valued as an important symbolic act. Although four inter-
viewees (two participants and two nonparticipants) acknowl-
edged that they themselves could not verify how data were 
managed at Lifelines, they still preferred to retain some form 
of control over what happened with and to their data.
Discussion
Our aim in this study was to understand why and how peo-
ple are willing to entrust their data to a facility engaged in 
centralized large-scale data repository for human research 
and what conditions would contribute to a reduction in their 
trust. Accordingly, we focused on possible differences in 
trust levels and in perceptions relating to data sharing 
among ex-participants, participants, and nonparticipants in 
a Dutch population-based biobank. Our results showed that 
evaluations of the biobank were related to its aim of being a 
public good and its grounding in medical science. Questions 
about its aims and nature as a public good and concerns 
about privacy seemed to be key factors influencing the 
withdrawal of participation and the building of trust. We 
found that the following four factors influenced trust build-
ing relating to centralized large-scale data repository for 
human research: data repository aimed at benefiting the 
public, the organizational aspects of the biobank as a data 
collector, characteristics of the collected data, and maintain-
ing control over personal data through informed consent.
Our results suggest that the medical scientific context is 
a key factor that influences the development of trust in bio-
banks and researchers in two ways. First, medical scientific 
research was generally perceived as trustworthy by partici-
pants and nonparticipants because it was considered benefi-
cial for society, with several respondents perceiving a 
population-based biobank as a charitable organization. In 
other words, the underlying purpose of the scientific medi-
cal field contributes to the trustworthiness of research orga-
nizations. Previous studies have shown that diminution of 
trust in providing data can be related to commercialism 
(Critchley et al., 2015; Nicol et al., 2016; Steinsbekk, 
Myskja, & Solberg, 2013). Our results showed that this was 
indeed one of the main concerns about participation, espe-
cially relating to its withdrawal.
Second, the context of medical sciences was perceived 
as trustworthy, entailing qualified organizations and repre-
sentatives. This perception reveals the importance of stan-
dardizing and harmonizing research systems based on 
clear principles, rules, and codes of conduct. It is never-
theless important to acknowledge that the contexts of 
medical science in other countries may be quite different 
and may not elicit similar degrees of trust (Sheikh & 
Hoeyer, 2018). Moreover, this factor has a bearing on the 
interpretation of the value placed by interviewees on 
informed consent. Our findings indicate that despite lack 
of recall of its content, informed consent was perceived by 
ex-participants, participants, and nonparticipants as a 
symbolic act to which a high moral value was assigned 
(Allen & Mcnamara, 2011).
The level of the interviewees’ trust in centralized large-
scale data repository or biobanking was also influenced by 
the organizational aspects of the biobank as the data collec-
tor. The large scale of data repository and the sound reputa-
tion or trustworthiness of the responsible organization 
motivated participants and some nonparticipants to provide 
personal data despite their lack of knowledge regarding cur-
rent security measures. Although providing data for 
Lifelines may entail risks concerning individuals’ privacy 
and autonomy, most participants and nonparticipants expe-
rienced a sense of safety relating to the number of other 
participants in the biobank. By contrast, the large scale of 
data repository elicited a higher degree of distrust among 
ex-participants and several other nonparticipants. Previous 
findings indicate that the perception of strength and safety 
in numbers accounts for one of the reduced risks and 
increased positive outcomes (Park & Hinsz, 2006). This 
finding of difference in trust is in line with that of previous 
studies, suggesting that differences between participants 
and nonparticipants may be attributed to predisposed differ-
ences in terms of their concerns or generalizations of trust. 
Such differences have a bearing on information collection 
procedures as well as on the acceptance of new methods for 
collecting data (Nobile et al., 2016).
The trustworthiness of the biobank as an organization 
was evaluated by the interviewees partly on the basis of 
their perceptions of the motives, behaviors, and competence 
demonstrated by employees or other representatives of the 
biobank. This finding endorses previous findings that inter-
personal relationships with health care representatives, such 
as general practitioners or biobank employees, matter in 
people’s decisions to participate in research (Johnsson, 
2013). The behaviors and communication styles of employ-
ees or other representatives of biobanks constitute the miss-
ing link, accounting for diminishing trust, as demonstrated 
by the ex-participants. This finding may indicate that trust 
in centralized large-scale data repository is linked to per-
ceptions of the trustworthiness of familiar entities (O’Neill, 
2018), such that the aims and competencies of representa-
tives are equated with the claims of the organization. 
Employees and representatives seem to be the gatekeepers 
of the bridge that stretches from trust, at one end of the 
spectrum, to distrust at the other. A lack of professionalism 
on their part is the final factor contributing to diminution of 
trust and the decision of individuals to withdraw their 
participation.
Ex-participants, nonparticipants, and even some partici-
pants had reservations about the process of combining 
information and data acquired from different contexts. The 
finding of the importance of the characteristics of the data, 
that is, their sensitivity and relevance to the research topic, 
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highlights the significance of the context when collecting 
data or linking data sets. This context is highly pertinent 
when considering the willingness of individuals to provide 
personal data. This challenges trends of centralizing data 
repositories in human research by internal and external 
linkage to other data sets, in particular to data sets about 
nonmedical contexts. Trust in a particular context and 
within organizations is contingent on the aims and norms 
that are valid in one context and is, therefore, of limited 
effectiveness in reducing complexity when attempting to 
optimize centralized large-scale data repositories. These 
findings are in line with scholastic views on privacy that 
consider context as a key factor underlying concern 
(Barocas & Nissenbaum, 2014). Moreover, they support the 
bioethics guidelines formulated in the United Kingdom that 
state that the sensitivity of data is contingent on the context 
in which they are used and related to other data (Nuffield 
Council on Bioethics, 2015).
The findings of this study confirmed that “blind trust” on 
the part of participants in human research organizations was 
induced by the “halo effects” of the responsible organiza-
tion and context (Hall et al., 2001). All (non)participants 
generalized their trust or distrust in the biobank and its con-
text relating to data linkages to simplify the decision of con-
tributing personal data. The level of risk associated, for 
example, with data optimization through linkages of data in 
a new setting can be estimated based on the experiences of 
interviewees combined with the perceived norms and val-
ues of the research organization or context. The role of trust 
therefore assumes prominence in decisions on whether or 
not to participate in research as a strategy for reducing com-
plexity (Luhmann, 1979), particularly when the nature of 
data repository becomes increasingly complex.
In general, the perceptions of ex-participants, partici-
pants, and nonparticipants on data sharing varied, with 
most participants being generally positive about central-
ized large-scale data repositories, focusing on opportuni-
ties that they offer rather than on threats. In contrast, 
nonparticipants and ex-participants had more concerns 
relating to these collections and offered reasons for these 
concerns. The findings of studies conducted among poten-
tial participants—4,659 and 15,650—in the United States 
and Europe, respectively, revealed similar attitudes 
(Gaskell et al., 2013; Kaufman et al., 2009). Although 90% 
of potential participants within a large cohort study in the 
United States expressed concerns about privacy, 60% of 
them stated that they would still participate in the study. 
The findings of the European study revealed that privacy 
concerns were less relevant to the intention to participate 
because of trust in key actors, for example, governments 
and universities. Therefore, the extension of existing trust 
seems to be an automatic process, whereas establishing 
trust from scratch could entail a cognitive rational process. 
This finding indicates that trust and distrust are distinct 
concepts in terms of structure. However, they are equal in 
terms of their functions and therefore feature in decisions 
about risk taking (Luhmann, 1979). This finding is in line 
with those of previous studies suggesting that participants 
and nonparticipants differ in intrapersonal characteristics, 
such as generalized trust and distrust, which have relevance 
for information collection procedures as well for accepting 
new data repository methods, such as big data (Nobile 
et al., 2016).
In addition to highlighting relevant factors of (non)par-
ticipation and trust in large-scale medical studies, our find-
ings raise some ethical questions about current 
responsibilities and mechanisms for protecting individuals’ 
integrity. The implementation of principles such as informed 
consent is highly valued in human research—apart from 
their being legally required—to protect participants’ integ-
rity (Eyal, 2014; Tassé & Kirby, 2017), and the implicit 
assumption underlying these principles is that participants 
are rational individuals. Our results revealed that when indi-
viduals need to decide whether or not to provide informa-
tion to a biobank, feelings of trust in general, the research 
context, and the reputation of the organization seem to be 
more relevant than knowledge about potential threats to 
their personal integrity. These factors may be even more rel-
evant to decisions relating to the acceptance of centralized 
data repository and data linkages.
The above discussion foregrounds the ethical issue of 
self-determination through one instance of detailed 
informed consent conceived as the basis of the consent and 
information process, particularly in relation to biobanks, 
which are public entities. When biobanks are perceived as 
charitable organizations, the societal context appears to be a 
prominent factor in the decision to entrust an organization 
with personal data. However, the current consent and infor-
mation-gathering procedures mainly focus on risks for indi-
viduals that are of a physical nature (Broekstra et al., 2017; 
D’Abramo, 2015). In light of these issues, our results sug-
gest that current procedures, such as broad informed con-
sent obtained in large cohort studies and biobanks 
(Steinsbekk, Myskja, & Solberg, 2013), are inadequate for 
safeguarding participants’ personal integrity and trust. On 
one hand, the societal context and potential implications of 
participation, such as reduced privacy, are not completely 
addressed, and on the other hand, participants are not pro-
tected against psychological biases at an individual level.
Best Practices
The combination of our findings leads to several recom-
mendations for the management of biorepositories and data 
repositories. First, the findings argue for an adoption of dif-
ferent measures in information and consent procedures, 
such as models of governance or consent based on solidar-
ity to ensure participants’ autonomy (Mittelstadt & Floridi, 
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2016; Prainsack & Buyx, 2013). These models can accom-
modate risks on individual as well as societal levels, given 
the focus on decreasing potential threats to individual par-
ticipants versus providing more complete and relevant 
information for research or other public goods. Second, it is 
important to design continuous communication strategies 
for participants and the public while taking into consider-
ation organizational aspects and characteristics of collected 
data that influence levels of trust, such as scale of organiza-
tion, quality of employees, or context of collected data. This 
finding highlights the moral responsibility of the scientific 
community to engage in public outreach regarding central-
ized large-scale data repository in scientific human research, 
especially in the medical sciences.
One strength of our study, which entailed the conduct of 
in-depth semi-structured interviews, is that it has shed 
some light on the complex decision-making process for 
providing personal data to a biobank. To the best of our 
knowledge, this study is the first to identify and compare 
factors associated with the trust of ex-participants, partici-
pants, and nonparticipants in centralized large-scale data 
repository for human research. Moreover, through its focus 
not only on members of the public as nonparticipants in 
data repository but also on ex-participants, the study has 
provided a broader perspective on decision making that 
pertains to the provision of personal data in centralized 
large-scale data repository.
The study revealed differences in the perceptions, con-
cerns, and elements entailed in trust building associated 
with the sharing of data among these three groups. This 
comparison of these three groups is, however, tentative, as 
the sample size was small, especially for the group of ex-
participants. Not surprisingly, most ex-participants who 
were approached, as well as their partners, were unwilling 
to participate in our study. The fact that the biobank itself 
recruited the ex-participants probably decreased their will-
ingness to participate in our study. Importantly, saturation 
occurred during the interviews held with participants and 
nonparticipants as well as with ex-participants, suggesting 
that our study results were not strongly affected by issues of 
representativeness for any of the three groups.
Research Agenda
The present study provides some initial evidence relating 
to the factors that determine individuals’ trust levels and 
their decisions to withdraw from participation in human 
research in the field of medical science. Our results point to 
the relevance of several factors, for example, the impor-
tance of capable and trustworthy representatives and the 
reputation of an organization. Evidently, further research 
on this topic is needed. For example, it seems worthwhile 
to focus on the potential role of individual characteristics 
entailed in generalized trust and the decision to share 
personal data with biobanks, especially via data linkages. 
These factors could be investigated more effectively using 
quantitative methods.
Furthermore, the results of our study suggest that knowl-
edge about risks, safety measures, and the benefits of tech-
nologies could raise concerns of privacy and security among 
some nonparticipants and ex-participants, especially in con-
texts where trust levels in data repository procedures are 
low. Proactive communication and information-gathering 
procedures are therefore critical for avoiding distrust. Two 
previous studies showed that an inverse relationship exists 
between perceived risks and perceived benefits, which 
determined the acceptance of technologies (Siegrist, 2000; 
Siegrist & Cvetkovich, 2000). Such a relationship was not, 
however, found for individuals who reported having knowl-
edge about these risks and benefits (Siegrist & Cvetkovich, 
2000). The conduct of more such quasi-experimental stud-
ies would contribute to an understanding of the effects of 
such interventions entailing communication and informa-
tion-gathering procedures. Furthermore, studies should 
focus on differences among domains of human research to 
determine which elements are decisive for trust building. 
Given that we only focused on the medical field, a compari-
son of different contexts would be pertinent.
Educational Implications
These findings suggest several courses of action for employ-
ees from data repositories in human research, and the 
researchers themselves. First, trust is enhanced by qualified 
and trustworthy employees, which may have training and 
educational implications for biobanks as public goods seek-
ing a large number of participants. Moreover, there is an 
important role for governments in providing guarantees of 
the commitments and competencies of institutes and repre-
sentatives within research systems via training and educa-
tion (Gilson, 2003). Second, proactive communication is 
key for preventing diminution of trust, in particular for 
changes in data collection. Trust and engagement can be 
enhanced through face-to-face contact (Gaskell et al., 
2013). Ex-participants reported that the organization or its 
representatives did not communicate proactively with them. 
Prevention of withdrawal of participation could, therefore, 
be done by being able to provide the right explanation on 
time, for example, about data security, organizational 
aspects, or limits of context of data repository.
Conclusion
In conclusion, the findings of the present study indicate that 
the decision to provide personal data for medical scientific 
research and to accept centralized data repository or data 
linkages is not one that is made easily. It relies heavily on 
generalized trust, which is built upon factors relating to the 
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context of data repository, but it is also contingent on indi-
viduals’ attitudes and values. Recent proposals relating to 
governance in biobanking (Mittelstadt & Floridi, 2016; 
Prainsack & Buyx, 2013) and informed consent (Budin-
Ljøsne et al., 2017) are heading in the direction of custom-
ization and greater transparency rather than focusing on 
individual participants and their needs. Contexts perceived 
as trustworthy, dynamic data governance, and informed 
consent models and ensuring benefits for the public from 
research may enhance potential participants’ willingness to 
provide personal data. These concepts foreground reciproc-
ity and interactions between researchers and (non)partici-
pants, with the aim of tailoring research within a wider 
context, thereby contributing to the building of trust in 
human research. However, challenges lie ahead for achiev-
ing the sustainable use of centralized large-scale data repos-
itories in human research.
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